Europe has the second highest share in the market due to increasing awareness among people over various neurological conditions.
Neurological conditions results in damage to the brain, spinal nerves or column that is caused by injury or illness. The precise causes for many of the neurological conditions are not yet known. These disorder can affect men and women, young and old and people from all cultures. Some of these neurological conditions are life-long and people can experience them onset at any time in their lives. Some of these conditions like cerebral palsy, are present from birth, and Alzheimer’s disease, Parkinson’s disease affect mainly older people. These disorders involve progressive deterioration in mental and physical capabilities which disrupts the patient and patient’s family. So, Neurotherapeutics are used for the treatment of traumas causing diseases.
Europe Neurotherapeutics Market is mainly driven by increasing aging population, growing R&D expenditure, a better understanding of the nature of neurologic diseases. Aged population are more susceptible to brain disorders. Therefore, the rise in aging population and life expectancy of the people will increase the market. The restraints that will hamper the growth of the market are restrictions by regulatory bodies on various technologies and drugs.
Based on Treatment, the market is segmented into Neurologic drugs and Neurologic devices. Neurologic drugs are further classified into oral administration, injections and others. Whereas neurologic devices are further categorized into Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS), transcranial magnetic stimulation, Deep Brain Stimulator, and others. Based on disorders, the market is segmented into Central Nervous system (CNS) disorders, Peripheral Nervous system (PNS) disorders, Autonomous Nervous system (ANS) disorders. Based on distribution channels the market is segmented into Hospitals, Neurotherapeutic center, Clinical research organizations, Clinics. Based on Geography, the Europe Neurotherapeutics market is analyzed under various regions namely U.K, Germany, France, Italy and Spain.
Download free sample report: http://www.marketdataforecast.com/market-reports/europe-neurotherapeutics-market-1272/request-sample
Some of the major players in Europe Neurotherapeutics Market are Abbott Laboratories, Inc., Becton, Novartis AG, Dickinson and Company, Pfizer, Inc., Johnson & Johnson, Biogen, Inc., GlaxoSmithKline, Inc., AstraZeneca plc, Sanofi-Aventis, Spiegelberg, stryker, Covidien, Medtronic, GE healthcare, and Merck & Co.
- Neurologic Drugs
-Electroconvulsive Therapy (ECT)
-Vagus Nerve Stimulation (VNS)
-Transcranial magnetic stimulation
-Deep Brain Stimulator
- Y-o-Y Growth Analysis, By Product
- Market Attractiveness Analysis, By Product
- Market Share Analysis, By Product
- Central Nervous system disorder
- Peripheral Nervous system disorder
- Autonomous Nervous system disorder
- Y-o-Y Growth Analysis, By Type
- Market Attractiveness Analysis, By Type
- Market Share Analysis, By Type
- Neurotherapeutic center
- Clinical Research organisations
- Y-o-Y Growth Analysis, By Application
- Market Attractiveness Analysis, By Application
- Market Share Analysis, By Application
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Team Lead (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases